Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
BMJ Open
|
September 14, 2024
Investigating the efficacy of acupuncture in treating patients with metabolic-associated fatty liver disease: a protocol for a randomised controlled clinical trial
Lihong Fu, Lingying Huang, Yueqiu Gao, et al.
Journal of Ethnopharmacology
|
April 15, 2024
Ba-Qi-Rougan formula alleviates hepatic fibrosis by suppressing hepatic stellate cell activation via the MSMP/CCR2/PI3K pathway
Yan Xue, Wanchun Zhu, Fengjie Qiao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
February 10, 2024
Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling
Xuemei Zhang, Xiaona Lu, Jia Shi, et al.
Medicine
|
December 23, 2025
ABCB1 rs2032582 variant is potentially linked withScutellariae Radix-induced liver injury: A case report
Yiwen Tang, Lihong Fu, Xinrui Ren, et al.
Heliyon
|
November 30, 2023
Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma
Rongjie Zhang, Qian Li, Xiaoxiao Yu, et al.
Scientific Reports
|
March 3, 2018
Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase
Zhuo Yu, Hai Feng, Xuehua Sun, et al.
Ebiomedicine
|
August 29, 2018
Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling
Haibin Song, Zhuo Yu, Xuehua Sun, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
July 6, 2020
Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation
Zhuo Yu, Hai Feng, Yunhui Zhuo, et al.
Journal of Ethnopharmacology
|
October 19, 2025
The mechanisms and therapeutic potential of Atractylodes macrocephala Koidz in chronic liver disease management
Junhua Feng, Xue Wang, Longshan Ji, et al.
Journal of Proteomics
|
July 7, 2025
Potential use of serum microvesicle indicators to distinguish different types of drug-induced liver injury
Lihong Fu, Liwen Zhang, Guangyuan Huo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
BMJ Open
|
September 14, 2024
Investigating the efficacy of acupuncture in treating patients with metabolic-associated fatty liver disease: a protocol for a randomised controlled clinical trial
Lihong Fu, Lingying Huang, Yueqiu Gao, et al.
Journal of Ethnopharmacology
|
April 15, 2024
Ba-Qi-Rougan formula alleviates hepatic fibrosis by suppressing hepatic stellate cell activation via the MSMP/CCR2/PI3K pathway
Yan Xue, Wanchun Zhu, Fengjie Qiao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
February 10, 2024
Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling
Xuemei Zhang, Xiaona Lu, Jia Shi, et al.
Medicine
|
December 23, 2025
ABCB1 rs2032582 variant is potentially linked withScutellariae Radix-induced liver injury: A case report
Yiwen Tang, Lihong Fu, Xinrui Ren, et al.
Heliyon
|
November 30, 2023
Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma
Rongjie Zhang, Qian Li, Xiaoxiao Yu, et al.
Scientific Reports
|
March 3, 2018
Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase
Zhuo Yu, Hai Feng, Xuehua Sun, et al.
Ebiomedicine
|
August 29, 2018
Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling
Haibin Song, Zhuo Yu, Xuehua Sun, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
July 6, 2020
Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation
Zhuo Yu, Hai Feng, Yunhui Zhuo, et al.
Journal of Ethnopharmacology
|
October 19, 2025
The mechanisms and therapeutic potential of Atractylodes macrocephala Koidz in chronic liver disease management
Junhua Feng, Xue Wang, Longshan Ji, et al.
Journal of Proteomics
|
July 7, 2025
Potential use of serum microvesicle indicators to distinguish different types of drug-induced liver injury
Lihong Fu, Liwen Zhang, Guangyuan Huo, et al.
Page
of 2